{"id":"W2560289362","doi":"10.1200/jco.2011.29.18_suppl.lba504","title":"Exemestane for primary prevention of breast cancer in postmenopausal women: NCIC CTG MAP.3—A randomized, placebo-controlled clinical trial.","year":2011,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Estrogen and related hormone effects","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"University Health Network","funders":"","keywords":"Medicine; Exemestane; Breast cancer; Tamoxifen; Raloxifene; Internal medicine; Gynecology; Oncology; Randomized controlled trial; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001524084,0.001463274,0.00274369,0.0007419328,0.0004890677,0.00105371,0.001190409,0.002464785,0.01060461],"category_scores_gemma":[0.001929687,0.0005667671,0.001651987,0.0006494227,0.0009044683,0.0008040644,0.0005214934,0.002378305,0.001261169],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009444971,"about_ca_system_score_gemma":0.001850955,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002203928,"about_ca_topic_score_gemma":0.006196977,"domain_scores_codex":[0.9993739,0.0003309229,0.00003432812,0.00008447105,0.00006494285,0.0001115025],"domain_scores_gemma":[0.9993831,0.0001221704,0.0001731143,0.00004274094,0.00004394348,0.0002349483],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.986317,0.002342225,0.0002870082,0.0007955364,0.0003744866,0.00002965026,0.00001636862,0.000086426,0.0009574824,0.00007860498,0.001175199,0.007540173],"study_design_scores_gemma":[0.9866508,0.01178766,0.0006794482,0.00004615803,0.0002028714,0.0000147201,0.000004825114,0.0001009814,0.00006702198,0.00005077079,0.0003899007,0.000004781605],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9193177,0.03181105,0.001119922,0.003865438,0.002034497,0.02488693,0.006909995,0.0006066127,0.009447839],"genre_scores_gemma":[0.937712,0.008626068,0.003106267,0.004882651,0.001795536,0.03163463,0.003771945,0.00004844386,0.008422517],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01060461,"threshold_uncertainty_score":0.03547591,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05053709135694542,"score_gpt":0.4167283492334085,"score_spread":0.3661912578764631,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}